Alexza Pharmaceuticals, Inc. (ALXA) Posts Q3 GAAP Loss of 19c/Share
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Loss from operations: -9.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss from operations: -9.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q3 GAAP loss of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $670 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
